Evidence map›Paper›PMID 41173363›Full record

ArticleMolecular metabolism2026

Cold exposure induces the constitutively active thermogenic receptor, GPR3, via ERRα and ERRγ.

Olivia Sveidahl Johansen, Rebecca L McIntyre, Janane F Rahbani, Qiaoqiao Zhang, Charlotte Scholtes, Damien Marc Lagarde, Cyrielle Billon, Isabelle Côté, Maria Delgado-Martin, David Tandio and 7 more

Abstract read
In one paragraph

Article in Molecular metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Olivia Sveidahl JohansenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
Rebecca L McIntyreNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark; Center for Adipocyte Signaling, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark.
Janane F RahbaniSection of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Qiaoqiao ZhangRosalind & Morris Goodman Cancer Institute and Department of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montreal, QC, H3G 1Y6, Canada.
Charlotte ScholtesRosalind & Morris Goodman Cancer Institute and Department of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montreal, QC, H3G 1Y6, Canada; Laboratoire CarMeN, UMR INSERM U1060/INRA U1397, Université Claude Bernard Lyon 1, F-69310 Pierre-Bénite and F-69500 Bron, France.
Damien Marc LagardeRosalind & Morris Goodman Cancer Institute and Department of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montreal, QC, H3G 1Y6, Canada.
Cyrielle BillonDepartment of Pharmaceutical and Administrative Sciences, Center for Clinical Pharmacology, Washington University School of Medicine and St. Louis College of Pharmacy, St. Louis, MO 63110, USA.
Isabelle CôtéDepartment of Cellular and Systems Pharmacology, University of Florida College of Pharmacy and University of Florida Genetics Institute, Gainesville, FL 32610, USA.
Maria Delgado-MartinRosalind & Morris Goodman Cancer Institute and Department of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montreal, QC, H3G 1Y6, Canada.
David TandioNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
Astrid Linde BasseNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark; Center for Adipocyte Signaling, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark.
Elodie EuryDepartment of Physiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Anastasia KralliDepartment of Physiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Thomas P BurrisDepartment of Cellular and Systems Pharmacology, University of Florida College of Pharmacy and University of Florida Genetics Institute, Gainesville, FL 32610, USA.
Vincent GiguèreRosalind & Morris Goodman Cancer Institute and Department of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montreal, QC, H3G 1Y6, Canada.
Lawrence KazakRosalind & Morris Goodman Cancer Institute and Department of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montreal, QC, H3G 1Y6, Canada.
Zachary Gerhart-HinesNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark; Center for Adipocyte Signaling, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark; Embark Laboratories ApS, Ottiliavej 9, 2500 Valby, Denmark; Incipiam Pharma ApS, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark. Electronic address: zpg@sund.ku.dk.

Funding

Regulators of adipocyte oxidative metabolismR01DK128933 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI KRALLI, ANASTASIA · 2022 to 2025
$1.9M
NIDDK NIH HHS R01 DK128933
6 · The paper itself

Abstract

objectivesDespite transformative advances in obesity pharmacotherapy, safely increasing energy expenditure remains a key unmet need. Exploiting thermogenic adipocytes represents a promising target given their capacity for significant catabolic activity. We previously showed that G protein-coupled receptor 3 (GPR3) can drive energy expenditure in brown and white mouse and human adipocytes. GPR3 is a unique GPCR because it displays high intrinsic activity and leads to constitutive cAMP signaling upon reaching the cell surface. Therefore, the transcriptional induction of GPR3 is analogous to ligand-binding activation of most GPCRs. Gpr3 expression is physiologically induced in thermogenic adipocytes by cold exposure, and mimicking this event through overexpression in mice is fully sufficient to increase energy expenditure and counteract metabolic disease. Yet the factors mediating physiological Gpr3 expression remain unknown.

methodsHere, we apply ATAC-Seq to identify cold-induced promoter elements of Gpr3. We uncover a role for the estrogen-related receptors, ERRα and ERRγ, in the physiological transcriptional control of Gpr3 using adipose-specific double knock-out mice with and without adeno-associated virus (AAV)-mediated rescue.

resultsWe show that ERRα directly binds the cold-induced promoter element of Gpr3 and that ERRα, ERRβ, and ERRγ each activate the Gpr3 promoter in vitro when co-transfected with PGC-1α. Adipocyte ERRα and ERRγ are required for the in vivo transcriptional induction of Gpr3 during cold exposure. Importantly, deficient Gpr3 cold-inducibility in adipose-specific ERRα and ERRγ KO mice is fully rescued by delivery of AAVs re-expressing either ERRα or ERRγ directly into brown adipose tissue.

conclusionsERRα and ERRγ are critical regulators of cold-induced transcription of Gpr3 and represent a targetable strategy for pharmacologically unlocking GPR3-induced energy expenditure.

Indexed as

Receptors, EstrogenReceptors, G-Protein-CoupledAdipocytesAnimalsCold TemperatureEnergy MetabolismERRalpha Estrogen-Related ReceptorHumansMaleMiceMice, Inbred C57BLMice, KnockoutPromoter Regions, GeneticThermogenesisERRalpha Estrogen-Related ReceptorEsrrg protein, mouseGPR3 protein, mouseReceptors, EstrogenReceptors, G-Protein-Coupledbrown adipose tissueERRαERRγGPR3G protein-coupled receptorsThermogenesisTranscriptional regulation

Identifiers

PMID41173363
PMCPMC12639564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.